Literature DB >> 27614462

Angioid streaks in aagenaes syndrome.

Viara Shoumnalieva-Ivanova1, Ivan Tanev1, Yani Zdravkov1, Simeon Monov2, Russka Shumnalieva3.   

Abstract

Aagenaes syndrome, also called lymphoedema cholestasis syndrome 1 (LSC1), is characterized by neonatal intrahepatic cholestasis, often lessening and becoming intermittent with age and severe chronic lymphoedema, mainly affecting the lower extremities. The condition is autosomal recessively inherited, and the gene is located on chromosome 15q. The locus, LCS1, was mapped to a 6.6 cM region on chromosome 15. Angioid streaks are visible irregular crack-like dehiscences in bruch's membrane that are associated with atrophic degeneration of the overlying retinal pigment epithelium. Angioid streaks have been described to be associated with pseudoxanthoma elasticum, paget's disease, sickle-cell anaemia, acromegaly, Ehlers-Danlos syndrome, and diabetes mellitus, but also appear in patients without any systemic diseases. Patients with angioid streaks are generally asymptomatic, unless the lesions extend towards the foveola or develop complications such as traumatic bruch's membrane rupture or macular choroidal neovascularization.

Entities:  

Keywords:  Aagenaes syndrome; Angioid streaks

Mesh:

Year:  2016        PMID: 27614462     DOI: 10.1007/s10792-016-0344-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  [Aagenaes syndrome--lymphedema and intrahepatic cholestasis].

Authors:  A Heiberg
Journal:  Tidsskr Nor Laegeforen       Date:  2001-05-30

2.  Mapping of the locus for cholestasis-lymphedema syndrome (Aagenaes syndrome) to a 6.6-cM interval on chromosome 15q.

Authors:  L N Bull; E Roche; E J Song; J Pedersen; A S Knisely; C B van Der Hagen; K Eiklid; O Aagenaes; N B Freimer
Journal:  Am J Hum Genet       Date:  2000-08-30       Impact factor: 11.025

3.  A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure.

Authors:  L Cai; B Struk; M D Adams; W Ji; T Haaf; H L Kang; S H Dho; X Xu; F Ringpfeil; J Nancarrow; S Zäch; L Schaen; M Stumm; T Niu; J Chung; K Lunze; B Verrecchia; L A Goldsmith; D Viljoen; L E Figuera; W Fuchs; M Lebwohl; J Uitto; R Richards; D Hohl; R Ramesar
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

4.  Evidence for genetic heterogeneity in lymphedema-cholestasis syndrome.

Authors:  Martin Frühwirth; Andreas R Janecke; Thomas Müller; Victoria E H Carlton; Florian Kronenberg; Felix Offner; A S Knisely; Silvana Geleff; Eyun J Song; Burkhard Simma; Alfred Königsrainer; Raimund Margreiter; C B van der Hagen; Kristin Eiklid; Oystein Aagenaes; Laura Bull; Helmut Ellemunter
Journal:  J Pediatr       Date:  2003-04       Impact factor: 4.406

5.  CCBE1 mutation in two siblings, one manifesting lymphedema-cholestasis syndrome, and the other, fetal hydrops.

Authors:  Sohela Shah; Laura K Conlin; Luis Gomez; Øystein Aagenaes; Kristin Eiklid; A S Knisely; Michael T Mennuti; Randolph P Matthews; Nancy B Spinner; Laura N Bull
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

6.  Angioid streaks, clinical course, complications, and current therapeutic management.

Authors:  Ilias Georgalas; Dimitris Papaconstantinou; Chrysanthi Koutsandrea; George Kalantzis; Dimitris Karagiannis; Gerasimos Georgopoulos; Ioannis Ladas
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.